fluoxetine has been researched along with Frigidity in 63 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Cyproheptadine has been used to counteract these side effects." | 5.28 | Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. ( Goldbloom, DS; Kennedy, SH, 1991) |
"Fifty-five outpatients with DSM-IV major depressive disorder and a confirmed history of intolerance to fluoxetine (mean final dose = 24." | 5.10 | Citalopram treatment of fluoxetine-intolerant depressed patients. ( Calabrese, JR; Londborg, PD; Shelton, MD; Thase, ME, 2003) |
"Five patients with depressive disorder who experienced sexual side effects during treatment with standard doses of fluoxetine (20 to 40 mg per day)." | 3.70 | Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. ( Ramasubbu, R, 1999) |
"Nine of 10 consecutively evaluated men with DSM-III-R nonparaphilic sexual addictions or paraphilias noted improvement in sexual behaviors and depressive symptomatology while treated with fluoxetine, imipramine, or lithium." | 3.68 | Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. ( Kafka, MP, 1991) |
" Doubling the low dosage in non-responders after 3 weeks resulted in a statistically significant improvement of CGI in the moclobemide group by comparison with the fluoxetine group at study end, suggesting that 600 mg moclobemide/day can still improve the patient's condition, while 40 mg fluoxetine/day does not." | 2.68 | Moclobemide versus fluoxetine for a major depressive episode. ( Haazen, L; Janne, P; Mirel, J; Parent, M; Reynaert, C, 1995) |
"Fluoxetine is an effective and well-tolerated treatment for this condition when used over time." | 2.67 | Long-term fluoxetine treatment of late luteal phase dysphoric disorder. ( Pearlstein, TB; Stone, AB, 1994) |
"Nefazodone treatment was associated with fewer side effects than were the control drugs." | 2.39 | The safety profile of nefazodone. ( Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC, 1996) |
"73) and moderate to high dosage of antidepressant (adjusted OR = 4." | 1.38 | Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine. ( Asmidar, D; Guan, NC; Hod, R; Jaafar, NR; Sidi, H, 2012) |
" WAY100635 attenuated the effect of fluoxetine; prior treatment with fluoxetine decreased 8-OH-DPAT's potency in reducing lordosis behavior; and progesterone shifted fluoxetine's dose-response curve to the right." | 1.36 | Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition. ( Guptarak, J; Hiegel, C; Sarkar, J; Uphouse, L, 2010) |
" The fates of SSRI-associated sexual adverse effects and clinical managements of restoring these side effects were described." | 1.29 | Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. ( Hsu, JH; Shen, WW, 1995) |
" Only a regular daily dosing schedule of amantadine has been used for the treatment of sexual dysfunction so far." | 1.29 | Intermittent amantadine for fluoxetine-induced anorgasmia. ( Balon, R, 1996) |
"Fluoxetine is a novel antidepressant known to block the reuptake of serotonin with little effect on other neurotransmitter systems." | 1.28 | The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. ( Fawcett, J; Guy, C; Jeffriess, H; Schaff, M; Zajecka, J, 1991) |
"Cyproheptadine has been used to counteract these side effects." | 1.28 | Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. ( Goldbloom, DS; Kennedy, SH, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 42 (66.67) | 18.2507 |
2000's | 18 (28.57) | 29.6817 |
2010's | 3 (4.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zargooshi, J | 1 |
Guptarak, J | 1 |
Sarkar, J | 1 |
Hiegel, C | 1 |
Uphouse, L | 1 |
Sidi, H | 2 |
Asmidar, D | 2 |
Hod, R | 1 |
Jaafar, NR | 1 |
Guan, NC | 2 |
Midi, M | 1 |
Kanagasundram, S | 1 |
Naing, L | 1 |
Oláh, KS | 1 |
Frye, CA | 1 |
Rhodes, ME | 1 |
Calabrese, JR | 1 |
Londborg, PD | 1 |
Shelton, MD | 1 |
Thase, ME | 1 |
Chollet, CA | 1 |
Andreatini, R | 1 |
Emery, M | 1 |
Senn, A | 1 |
Wisard, M | 1 |
Germond, M | 1 |
Oguzhanoglu, NK | 1 |
Ozdel, O | 1 |
Aybek, Z | 1 |
Nelson, JC | 1 |
Portera, L | 1 |
Leon, AC | 1 |
Csoka, AB | 1 |
Shipko, S | 1 |
Mercado, MG | 1 |
Kimmer, SL | 1 |
Holman, JR | 1 |
Wanserski, G | 1 |
Lo, V | 1 |
Rothschild, AJ | 2 |
Reynaert, C | 1 |
Parent, M | 1 |
Mirel, J | 1 |
Janne, P | 1 |
Haazen, L | 1 |
Althof, SE | 1 |
Segraves, RT | 1 |
Kaplan, PM | 1 |
Pearlstein, TB | 1 |
Stone, AB | 1 |
Forster, P | 1 |
King, J | 1 |
Power-Smith, P | 1 |
Walker, PW | 1 |
Cole, JO | 1 |
Gardner, EA | 1 |
Hughes, AR | 1 |
Johnston, JA | 1 |
Batey, SR | 1 |
Lineberry, CG | 1 |
Balon, R | 4 |
Yeragani, VK | 1 |
Pohl, R | 1 |
Ramesh, C | 1 |
Patterson, WM | 1 |
Terao, T | 2 |
Benazzi, F | 1 |
Shen, WW | 2 |
Hsu, JH | 1 |
Robinson, DS | 1 |
Roberts, DL | 1 |
Smith, JM | 1 |
Stringfellow, JC | 1 |
Kaplita, SB | 1 |
Seminara, JA | 1 |
Marcus, RN | 1 |
Aizenberg, D | 1 |
Zemishlany, Z | 1 |
Weizman, A | 1 |
Ellison, JM | 2 |
Montejo-González, AL | 1 |
Llorca, G | 1 |
Izquierdo, JA | 1 |
Ledesma, A | 1 |
Bousoño, M | 1 |
Calcedo, A | 1 |
Carrasco, JL | 1 |
Ciudad, J | 1 |
Daniel, E | 1 |
De la Gandara, J | 1 |
Derecho, J | 1 |
Franco, M | 1 |
Gomez, MJ | 1 |
Macias, JA | 1 |
Martin, T | 1 |
Perez, V | 1 |
Sanchez, JM | 1 |
Sanchez, S | 1 |
Vicens, E | 1 |
Kindler, S | 1 |
Dolberg, OT | 1 |
Cohen, H | 1 |
Hirschmann, S | 1 |
Kotler, M | 1 |
Reich, J | 1 |
Nelson, EB | 1 |
Keck, PE | 1 |
McElroy, SL | 1 |
Labbate, LA | 1 |
Grimes, JB | 1 |
Hines, A | 1 |
Pollack, MH | 2 |
DeLuca, P | 1 |
Ramasubbu, R | 1 |
Fava, M | 1 |
Amsterdam, JD | 1 |
Deltito, JA | 1 |
Salzman, C | 1 |
Schwaller, M | 1 |
Dunner, DL | 1 |
Farah, A | 1 |
Pallanti, S | 1 |
Koran, LM | 1 |
Urosevich, Z | 1 |
Clayton, DO | 1 |
Michelson, D | 1 |
Bancroft, J | 1 |
Targum, S | 1 |
Kim, Y | 1 |
Tepner, R | 1 |
Musa, MN | 1 |
Staneluis, JM | 1 |
Michael, A | 1 |
O'Donnell, EA | 1 |
Ferguson, JM | 1 |
Altman, CA | 1 |
Brubaker, RV | 1 |
Hollander, E | 1 |
McCarley, A | 1 |
Jacobsen, FM | 1 |
Cohen, AJ | 1 |
Balogh, S | 1 |
Hendricks, SE | 1 |
Kang, J | 1 |
Kafka, MP | 1 |
Zajecka, J | 1 |
Fawcett, J | 1 |
Schaff, M | 1 |
Jeffriess, H | 1 |
Guy, C | 1 |
Feder, R | 1 |
Goldbloom, DS | 1 |
Kennedy, SH | 1 |
McCormick, S | 1 |
Olin, J | 1 |
Brotman, AW | 2 |
Herman, JB | 1 |
Falk, WE | 1 |
Biederman, J | 1 |
Rosenbaum, JF | 1 |
Musher, JS | 1 |
7 reviews available for fluoxetine and Frigidity
Article | Year |
---|---|
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relatio | 1995 |
The safety profile of nefazodone.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agent | 1996 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; | 1996 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pros | 1997 |
Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Male; Piperazines; Puri | 1999 |
Sexual side effects of antidepressants.
Topics: Adult; Antidepressive Agents; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Incidenc | 2000 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 2001 |
12 trials available for fluoxetine and Frigidity
Article | Year |
---|---|
Citalopram treatment of fluoxetine-intolerant depressed patients.
Topics: Adult; Aged; Citalopram; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Headache; Humans; | 2003 |
Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Depression; Depressive Disorder; Double-Blin | 2005 |
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug | 1995 |
Moclobemide versus fluoxetine for a major depressive episode.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Dose-Response Relat | 1995 |
Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
Topics: Adult; Age of Onset; Comorbidity; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans | 1994 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pros | 1997 |
The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Ejaculation; Fl | 1997 |
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Topics: Adult; Ambulatory Care; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Fema | 1998 |
Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Therapy, Combination; Female; Fluox | 1999 |
Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
Topics: Adult; Amantadine; Anxiety Disorders; Buspirone; Depressive Disorder; Dopamine Agents; Female; Fluox | 2000 |
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.
Topics: Adult; Clomipramine; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Ne | 1992 |
Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Topics: Adult; Depressive Disorder; Erectile Dysfunction; Female; Fluoxetine; Humans; Libido; Male; Middle A | 1992 |
45 other studies available for fluoxetine and Frigidity
Article | Year |
---|---|
Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients.
Topics: Adolescent; Adult; Aged; Clomipramine; Erectile Dysfunction; Female; Fluoxetine; Follow-Up Studies; | 2008 |
Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dose-Response Relationship, Drug; Female; Fluoxetin | 2010 |
Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
Topics: Adolescent; Adult; Aged; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Dose-Respo | 2012 |
Sexual arousal difficulties in women treated with antidepressants: a comparison between escitalopram and fluoxetine.
Topics: Adult; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Dose- | 2012 |
The use of fluoxetine (Prozac) in premenstrual syndrome: is the incidence of sexual dysfunction and anorgasmia acceptable?
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Middle Aged; Premenstru | 2002 |
Zaprinast, a phosphodiesterase 5 inhibitor, overcomes sexual dysfunction produced by fluoxetine, a selective serotonin reuptake inhibitor in hamsters.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cricetinae; Cyclic Nucleotide Phosphodiesterases, Type | 2003 |
Effect of bupropion on sexual dysfunction induced by fluoxetine: a case report of hypersexuality.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Drug Interac | 2003 |
Ejaculation failure on the day of oocyte retrieval for IVF: case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cryopreservation; Depression; Ejaculation; | 2004 |
The efficacy of fluoxetine and a stop-start technique in the treatment of premature ejaculation and anxiety.
Topics: Adult; Anxiety; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Sexual Dysfunctions, Psychologic | 2005 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonist | 2006 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; | 2008 |
Treatment of drug-induced anorgasmia.
Topics: Female; Fluoxetine; Humans; Male; Orgasm; Paroxetine; Sexual Dysfunctions, Psychological; Yohimbine | 1994 |
The use of serotonergic uptake inhibitors in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Ejaculation; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibito | 1994 |
Fluoxetine for premature ejaculation.
Topics: Adult; Ejaculation; Fluoxetine; Humans; Male; Sexual Behavior; Sexual Dysfunctions, Psychological | 1994 |
Beneficial sexual side-effects from fluoxetine.
Topics: Aged; Depressive Disorder; Erectile Dysfunction; Fluoxetine; Humans; Male; Penile Erection; Sexual B | 1994 |
Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
Topics: Ambulatory Care; Bupropion; Depressive Disorder; Female; Fluoxetine; Humans; Libido; Male; Middle Ag | 1993 |
Sexual dysfunction during antidepressant treatment.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; | 1993 |
Fluoxetine-induced sexual dysfunction.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Ejaculation; Fluoxetine; Huma | 1993 |
Titration of serotonin reuptake blockers.
Topics: Amantadine; Drug Administration Schedule; Fluoxetine; Humans; Mental Disorders; Recurrence; Selectiv | 1993 |
Fluoxetine-induced sexual dysfunction and yohimbine.
Topics: Drug Therapy, Combination; Fluoxetine; Humans; Male; Penile Erection; Priapism; Sexual Dysfunctions, | 1993 |
Involuntary sperm emission with fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Dru | 1995 |
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido | 1995 |
Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors.
Topics: Adult; Clomipramine; Cyproheptadine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Sel | 1995 |
Exercise-induced orgasms associated with fluoxetine treatment of depression.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Exercise; Female; Fluoxetine; Humans; Middle | 1996 |
Intermittent amantadine for fluoxetine-induced anorgasmia.
Topics: Adult; Amantadine; Dopamine Agents; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibit | 1996 |
The sexual side effects of an SSRI treated by behavioral methods.
Topics: Adult; Behavior Therapy; Depressive Disorder; Female; Fluoxetine; Humans; Masturbation; Self Care; S | 1997 |
Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron.
Topics: Drug Administration Schedule; Female; Fluoxetine; Granisetron; Humans; Middle Aged; Premenstrual Syn | 1997 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Dis | 1997 |
Fluoxetine-induced genital anesthesia relieved by Ginkgo biloba extract.
Topics: Adult; Female; Flavonoids; Fluoxetine; Genitalia, Female; Ginkgo biloba; Humans; Hypesthesia; Plant | 1998 |
Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Depressive Disor | 1999 |
Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
Topics: Aged; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptak | 1999 |
Adverse events of fluoxetine: postmarketing compared with premarketing clinical trials.
Topics: Chi-Square Distribution; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administra | 2000 |
Fluoxetine-induced sexual dysfunction reversed by trazodone.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Humans; Sexual Dysfunctions, Psychological; Trazodon | 2000 |
Female sexual dysfunction and antidepressant use.
Topics: Amantadine; Antidepressive Agents; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combina | 2001 |
Effects of selective serotonin reuptake inhibitors on sexual function.
Topics: Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psycho | 2001 |
Fluoxetine-induced sexual dysfunction reversed by loratadine.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxet | 2002 |
Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment.
Topics: Cyproheptadine; Depressive Disorder; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Sexual Dysfuncti | 1992 |
Treatment of fluoxetine-induced anorgasmia with amantadine.
Topics: Adult; Amantadine; Depressive Disorder; Fluoxetine; Humans; Male; Orgasm; Sexual Dysfunctions, Psych | 1992 |
Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Imipramine; Lithium; Male; Ma | 1991 |
The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
Topics: Adult; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Iatrogenic Disease; Male; M | 1991 |
Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients.
Topics: Adult; Cyproheptadine; Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Male; Middle Aged | 1991 |
Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa.
Topics: Adult; Bulimia; Cyproheptadine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Hu | 1991 |
Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients.
Topics: Adult; Cyproheptadine; Depressive Disorder; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Orga | 1990 |
Fluoxetine-induced sexual dysfunction.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Female; Fluoxetine; Humans; Male; Mi | 1990 |
Anorgasmia with the use of fluoxetine.
Topics: Depressive Disorder; Female; Fluoxetine; Humans; Male; Orgasm; Sexual Dysfunctions, Psychological | 1990 |